Novartis Korea said that Exelon Patch (rivastigmine transdermal patch), the first transdermal therapy for mild-to-moderate Alzheimer's disease, has been included in a list of insurance-covered medicines from February 2.
The one-daily Exelon Patch 5 and 10 are valued at 3,077 won and 3,100, respectively (contact: TEL 080-768-0800).
Transdermal patches are designed to provide controlled, co...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.